Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vestergaard

Showing results (1-10 of 519) with videos related to

Pageof 52
Sort By:
Ugeskrift for Laeger|March 22, 2012
[Denosumab--treatment of osteoporosis and cancer]Peter Vestergaard
Handbook of Experimental Pharmacology|January 1, 2020
Drugs Causing Bone LossPeter Vestergaard
Current Drug Safety|August 12, 2008
Skeletal effects of systemic and topical corticosteroidsPeter Vestergaard
Current Drug Safety|August 12, 2008
Pain-relief medication and risk of fracturesPeter Vestergaard
Expert Review of Neurotherapeutics|December 24, 2008
Fracture risks of antidepressantsPeter Vestergaard
Calcified Tissue International|June 29, 2011
Risk of newly diagnosed type 2 diabetes is reduced in users of alendronatePeter Vestergaard
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 9, 2026
From frail bones that could not last long to strong bones that support a good and long life-the story of osteogenesis imperfectaPeter Vestergaard
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Bone metabolism in type 2 diabetes and role of thiazolidinedionesPeter Vestergaard
Therapeutic Advances in Musculoskeletal Disease|December 2, 2014
New strategies for osteoporosis patients previously managed with strontium ranelatePeter Vestergaard
Annales D'Endocrinologie|April 26, 2015
Primary hyperparathyroidism and nephrolithiasisPeter Vestergaard
Pageof 52

Showing results (1-10 of 519) with videos related to

Sort By:
Pageof 52
Ugeskrift for Laeger|March 22, 2012
[Denosumab--treatment of osteoporosis and cancer]Peter Vestergaard
Handbook of Experimental Pharmacology|January 1, 2020
Drugs Causing Bone LossPeter Vestergaard
Current Drug Safety|August 12, 2008
Skeletal effects of systemic and topical corticosteroidsPeter Vestergaard
Current Drug Safety|August 12, 2008
Pain-relief medication and risk of fracturesPeter Vestergaard
Expert Review of Neurotherapeutics|December 24, 2008
Fracture risks of antidepressantsPeter Vestergaard
Calcified Tissue International|June 29, 2011
Risk of newly diagnosed type 2 diabetes is reduced in users of alendronatePeter Vestergaard
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 9, 2026
From frail bones that could not last long to strong bones that support a good and long life-the story of osteogenesis imperfectaPeter Vestergaard
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Bone metabolism in type 2 diabetes and role of thiazolidinedionesPeter Vestergaard
Therapeutic Advances in Musculoskeletal Disease|December 2, 2014
New strategies for osteoporosis patients previously managed with strontium ranelatePeter Vestergaard
Annales D'Endocrinologie|April 26, 2015
Primary hyperparathyroidism and nephrolithiasisPeter Vestergaard
Pageof 52